A Study of YL202 in Selected Patients With Advanced Solid Tumors

Clinical trial NCT06107686 · RECRUITING

Trial details

NCT number: NCT06107686
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Breast Cancer HNSCC Locally Advanced or Metastatic Solid Tumors

Start date: 2023-12-15
Primary completion: 2026-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.